The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMedium•24 March 2026•

1 min read

Medtronic and Merit Medical Partner to Expand Chronic Pain Portfolio via ViaVerte System

Key Facts

1Medtronic entered into a distribution agreement with Merit Medical Systems to offer the FDA-cleared ViaVerte system.

2The ViaVerte system is the first physician-controlled basivertebral nerve ablation (BVNA) system for treating chronic lower-back pain.

3The agreement aims to expand Medtronic's portfolio of pain intervention treatments.

Medtronic plc (MDT) and Merit Medical Systems, Inc. (MMSI) have announced a strategic distribution agreement for the innovative ViaVerte system. The ViaVerte system is the first FDA-cleared, physician-controlled basivertebral nerve ablation (BVNA) technology designed to treat chronic vertebrogenic lower-back pain. This partnership aims to integrate the advanced system into Medtronic's extensive pain intervention portfolio, enhancing its offerings in the minimally invasive surgery market. For Merit Medical, the deal provides a significant opportunity to leverage Medtronic's global distribution network and clinical expertise. The move is expected to improve patient access to advanced pain management solutions while strengthening the competitive position of both companies. Analysts view the collaboration as a bullish development, reflecting a strategic alignment in the high-growth medical device sector.

Create Free Account